🇺🇸 FDA
Pipeline program

cell sheet pellets and cell sheet fragment

TEFMMU

Phase 2 mab active

Quick answer

cell sheet pellets and cell sheet fragment for Chronic Periodontitis is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Chronic Periodontitis
Phase
Phase 2
Modality
mab
Status
active

Clinical trials